Cargando…

Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma

BACKGROUND: Over the past decade, newly designed cancer therapies have not significantly improved the survival of patients diagnosed with Malignant Pleural Mesothelioma (MPM). Among a limited number of genes that are frequently mutated in MPM several of them encode proteins that belong to the HIPPO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pulito, Claudio, Korita, Etleva, Sacconi, Andrea, Valerio, Mariacristina, Casadei, Luca, Lo Sardo, Federica, Mori, Federica, Ferraiuolo, Maria, Grasso, Giuseppe, Maidecchi, Anna, Lucci, Jacopo, Sudol, Marius, Muti, Paola, Blandino, Giovanni, Strano, Sabrina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689183/ https://www.ncbi.nlm.nih.gov/pubmed/31399037 http://dx.doi.org/10.1186/s13046-019-1352-3

Ejemplares similares

Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferation
por: Canu, Valeria, et al.
Publicado: (2020)

Cynara scolymus affects malignant pleural mesothelioma by promoting apoptosis and restraining invasion
por: Pulito, Claudio, et al.
Publicado: (2015)

Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects
por: Mori, Federica, et al.
Publicado: (2016)

YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting
por: Lo Sardo, Federica, et al.
Publicado: (2018)

Cdx2 Polymorphism Affects the Activities of Vitamin D Receptor in Human Breast Cancer Cell Lines and Human Breast Carcinomas
por: Pulito, Claudio, et al.
Publicado: (2015)

The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53/YAP/TEAD transcription-competent complex
por: Verduci, Lorena, et al.
Publicado: (2017)

Metformin-induced metabolic reprogramming of chemoresistant ALDH(bright) breast cancer cells
por: Cioce, Mario, et al.
Publicado: (2014)

Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers
por: Ferraiuolo, Maria, et al.
Publicado: (2017)

Melatonin and Hippo Pathway: Is There Existing Cross-Talk?
por: Lo Sardo, Federica, et al.
Publicado: (2017)

A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy
por: Pobbati, Ajaybabu V., et al.
Publicado: (2020)

Long Non-coding MIR205HG Depletes Hsa-miR-590-3p Leading to Unrestrained Proliferation in Head and Neck Squamous Cell Carcinoma
por: Di Agostino, Silvia, et al.
Publicado: (2018)

Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex
por: Kaan, Hung Yi Kristal, et al.
Publicado: (2017)

FLNC Expression Level Influences the Activity of TEAD-YAP/TAZ Signaling
por: Knyazeva, Anastasia, et al.
Publicado: (2020)

Protein-Protein Interaction Disruptors of the YAP/TAZ-TEAD Transcriptional Complex
por: Pobbati, Ajaybabu V., et al.
Publicado: (2020)

The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
por: Cunningham, Richard, et al.
Publicado: (2022)

Identification of Celastrol as a Novel YAP-TEAD Inhibitor for Cancer Therapy by High Throughput Screening with Ultrasensitive YAP/TAZ–TEAD Biosensors
por: Nouri, Kazem, et al.
Publicado: (2019)

MicroRNAs: short non-coding players in cancer chemoresistance
por: Donzelli, Sara, et al.
Publicado: (2014)

The Telluride YAP/TAZ and TEAD Workshop: A Small Meeting with a Big Impact
por: Weinberg, Guy L., et al.
Publicado: (2023)

Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention
por: Pulito, Claudio, et al.
Publicado: (2013)

A YAP/TAZ-TEAD signalling module links endothelial nutrient acquisition to angiogenic growth
por: Ong, Yu Ting, et al.
Publicado: (2022)

Convergence of YAP/TAZ, TEAD and TP63 activity is associated with bronchial premalignant severity and progression
por: Ning, Boting, et al.
Publicado: (2023)

The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment
por: Mokhtari, Reza Bayat, et al.
Publicado: (2023)

Aurintricarboxylic acid is a canonical disruptor of the TAZ-TEAD transcriptional complex
por: Che, Kepeng, et al.
Publicado: (2022)

Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities
por: Pulito, Claudio, et al.
Publicado: (2017)

Zebrafish mutants and TEAD reporters reveal essential functions for Yap and Taz in posterior cardinal vein development
por: Astone, Matteo, et al.
Publicado: (2018)

Targeting YAP/TAZ-TEAD protein-protein interactions using fragment-based and computational modeling approaches
por: Kaan, Hung Yi Kristal, et al.
Publicado: (2017)

TEADs, Yap, Taz, Vgll4s transcription factors control the establishment of Left-Right asymmetry in zebrafish
por: Fillatre, Jonathan, et al.
Publicado: (2019)

Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma
por: Laraba, Liyam, et al.
Publicado: (2022)

Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients
por: Sacconi, Andrea, et al.
Publicado: (2023)

The miR-205-5p/BRCA1/RAD17 Axis Promotes Genomic Instability in Head and Neck Squamous Cell Carcinomas
por: Valenti, Fabio, et al.
Publicado: (2019)

Role of the YAP/TAZ-TEAD Transcriptional Complex in the Metabolic Control of TRAIL Sensitivity by the Mevalonate Pathway in Cancer Cells
por: El Yousfi, Younes, et al.
Publicado: (2023)

Dihydroartemisinin: from malaria to the treatment of relapsing head and neck cancers
por: Pulito, Claudio, et al.
Publicado: (2020)

MiR-204 down-regulation elicited perturbation of a gene target signature common to human cholangiocarcinoma and gastric cancer
por: Canu, Valeria, et al.
Publicado: (2017)

Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells
por: Spagnuolo, Manuela, et al.
Publicado: (2019)

The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis
por: Zinatizadeh, Mohammad Reza, et al.
Publicado: (2019)

miR-181c associates with tumor relapse of high grade osteosarcoma
por: Federica, Mori, et al.
Publicado: (2015)

YAP1/TAZ-TEAD transcriptional networks maintain skin homeostasis by regulating cell proliferation and limiting KLF4 activity
por: Yuan, Yao, et al.
Publicado: (2020)

Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells
por: Van Sciver, Nicholas, et al.
Publicado: (2021)

Knockdown of HSP110 attenuates hypoxia-induced pulmonary hypertension in mice through suppression of YAP/TAZ-TEAD4 pathway
por: Liu, Haitao, et al.
Publicado: (2022)

An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance
por: Hagenbeek, Thijs J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_huk789ocgakjshrjhkdbbdu0hs